PHARMACYTE BIOTECH, INC. Short-term Debt
PHARMACYTE BIOTECH, INC. (PMCB) had Short-term Debt of $2.21 million as of 2012-01-31, per its 10-Q filed 2012-03-21.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:ShortTermBorrowings · last filed 2012-03-21
- 2012-01-31: Short-term Debt $2.21M.
- 2011-10-31: Short-term Debt $2.37M.
- 2011-07-31: Short-term Debt $2.37M.
- 2011-04-30: Short-term Debt $2.37M.
| Period end | Short-term Debt |
|---|---|
| 2012-01-31 | $2.21M 10-Q · filed 2012-03-21 |
| 2011-10-31 | $2.37M 10-Q · filed 2011-12-15 |
| 2011-07-31 | $2.37M 10-Q/A · filed 2011-09-20 |
| 2011-04-30 | $2.37M 10-Q · filed 2012-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |